These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 17474664)
21. Managing the premenstrual syndrome. Drug Ther Bull; 1992 Aug; 30(18):69-72. PubMed ID: 1396112 [No Abstract] [Full Text] [Related]
22. Suppression of cyclical ovarian function in the treatment of severe premenstrual syndrome. Studd J Menopause Int; 2007 Dec; 13(4):182-4. PubMed ID: 18088531 [No Abstract] [Full Text] [Related]
23. Pyridoxine supplements in the premenstrual syndrome. Barr W Practitioner; 1984 Apr; 228(1390):425-7. PubMed ID: 6539473 [No Abstract] [Full Text] [Related]
24. [Premenstrual tension and absenteeism. Beneficial effects of treatment with bendroflumethiazide and fluphenazine]. Ottaviano I Folia Med (Napoli); 1968 Sep; 51(9):704-14. PubMed ID: 5752802 [No Abstract] [Full Text] [Related]
25. [Therapy of premenstrual syndrome with thiomucase-H]. Hauser GA Ther Umsch; 1983 Jul; 40(7):610-4. PubMed ID: 6684803 [No Abstract] [Full Text] [Related]
26. Hormonal management of premenstrual syndrome. Usman SB; Indusekhar R; O'Brien S Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457 [TBL] [Abstract][Full Text] [Related]
27. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. Agha-Hosseini M; Kashani L; Aleyaseen A; Ghoreishi A; Rahmanpour H; Zarrinara AR; Akhondzadeh S BJOG; 2008 Mar; 115(4):515-9. PubMed ID: 18271889 [TBL] [Abstract][Full Text] [Related]
28. [Study of the effect of a diuretic-proteolytic enzymes combination in the premenstrual syndrome]. Chastrusse L; Dufourniaud J; Rigo V J Med Bord; 1966 Mar; 143(3):399-404. PubMed ID: 5948590 [No Abstract] [Full Text] [Related]
30. [Treatment of premenstrual syndrome. Results obtained with Chymodrex]. Linquette M; Gasnault JP Lille Med; 1967 May; 12(4):Suppl:529-33. PubMed ID: 5630041 [No Abstract] [Full Text] [Related]
31. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092 [TBL] [Abstract][Full Text] [Related]
38. Discussion: 'Add-back regimens in patients using a GnRH agonist for premenstrual dysphoric disorder' by Segebladh et al. Jungheim ES; Kenerson JJ; Foyouzi-Yousefi N; Allsworth JE; Marquard KL Am J Obstet Gynecol; 2009 Aug; 201(2):e1-5. PubMed ID: 19646561 [TBL] [Abstract][Full Text] [Related]
39. Dihydroergotamine: role in the treatment of migraine. Schürks M Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283 [TBL] [Abstract][Full Text] [Related]
40. The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study. Gerhardsen G; Hansen AV; Killi M; Fornitz GG; Pedersen F; Roos SB Adv Ther; 2008 Jun; 25(6):595-607. PubMed ID: 18568441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]